Influenza Medication Market - Global Outlook and Forecast 2021-2027

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Influenza Medication Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Influenza Medication Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Influenza Medication Overall Market Size
2.1 Global Influenza Medication Market Size: 2021 VS 2027
2.2 Global Influenza Medication Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Influenza Medication Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Influenza Medication Players in Global Market
3.2 Top Global Influenza Medication Companies Ranked by Revenue
3.3 Global Influenza Medication Revenue by Companies
3.4 Global Influenza Medication Sales by Companies
3.5 Global Influenza Medication Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Influenza Medication Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Influenza Medication Product Type
3.8 Tier 1, Tier 2 and Tier 3 Influenza Medication Players in Global Market
3.8.1 List of Global Tier 1 Influenza Medication Companies
3.8.2 List of Global Tier 2 and Tier 3 Influenza Medication Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Influenza Medication Market Size Markets, 2021 & 2027
4.1.2 Zanamivir
4.1.3 Oseltamivir
4.1.4 Peramivir
4.1.5 Amantadine
4.1.6 Rimantadine
4.1.7 Inosine
4.1.8 Others
4.2 By Type - Global Influenza Medication Revenue & Forecasts
4.2.1 By Type - Global Influenza Medication Revenue, 2016-2021
4.2.2 By Type - Global Influenza Medication Revenue, 2022-2027
4.2.3 By Type - Global Influenza Medication Revenue Market Share, 2016-2027
4.3 By Type - Global Influenza Medication Sales & Forecasts
4.3.1 By Type - Global Influenza Medication Sales, 2016-2021
4.3.2 By Type - Global Influenza Medication Sales, 2022-2027
4.3.3 By Type - Global Influenza Medication Sales Market Share, 2016-2027
4.4 By Type - Global Influenza Medication Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Influenza Medication Market Size, 2021 & 2027
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Pharmacies
5.1.5 Others
5.2 By Application - Global Influenza Medication Revenue & Forecasts
5.2.1 By Application - Global Influenza Medication Revenue, 2016-2021
5.2.2 By Application - Global Influenza Medication Revenue, 2022-2027
5.2.3 By Application - Global Influenza Medication Revenue Market Share, 2016-2027
5.3 By Application - Global Influenza Medication Sales & Forecasts
5.3.1 By Application - Global Influenza Medication Sales, 2016-2021
5.3.2 By Application - Global Influenza Medication Sales, 2022-2027
5.3.3 By Application - Global Influenza Medication Sales Market Share, 2016-2027
5.4 By Application - Global Influenza Medication Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Influenza Medication Market Size, 2021 & 2027
6.2 By Region - Global Influenza Medication Revenue & Forecasts
6.2.1 By Region - Global Influenza Medication Revenue, 2016-2021
6.2.2 By Region - Global Influenza Medication Revenue, 2022-2027
6.2.3 By Region - Global Influenza Medication Revenue Market Share, 2016-2027
6.3 By Region - Global Influenza Medication Sales & Forecasts
6.3.1 By Region - Global Influenza Medication Sales, 2016-2021
6.3.2 By Region - Global Influenza Medication Sales, 2022-2027
6.3.3 By Region - Global Influenza Medication Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Influenza Medication Revenue, 2016-2027
6.4.2 By Country - North America Influenza Medication Sales, 2016-2027
6.4.3 US Influenza Medication Market Size, 2016-2027
6.4.4 Canada Influenza Medication Market Size, 2016-2027
6.4.5 Mexico Influenza Medication Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Influenza Medication Revenue, 2016-2027
6.5.2 By Country - Europe Influenza Medication Sales, 2016-2027
6.5.3 Germany Influenza Medication Market Size, 2016-2027
6.5.4 France Influenza Medication Market Size, 2016-2027
6.5.5 U.K. Influenza Medication Market Size, 2016-2027
6.5.6 Italy Influenza Medication Market Size, 2016-2027
6.5.7 Russia Influenza Medication Market Size, 2016-2027
6.5.8 Nordic Countries Influenza Medication Market Size, 2016-2027
6.5.9 Benelux Influenza Medication Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Influenza Medication Revenue, 2016-2027
6.6.2 By Region - Asia Influenza Medication Sales, 2016-2027
6.6.3 China Influenza Medication Market Size, 2016-2027
6.6.4 Japan Influenza Medication Market Size, 2016-2027
6.6.5 South Korea Influenza Medication Market Size, 2016-2027
6.6.6 Southeast Asia Influenza Medication Market Size, 2016-2027
6.6.7 India Influenza Medication Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Influenza Medication Revenue, 2016-2027
6.7.2 By Country - South America Influenza Medication Sales, 2016-2027
6.7.3 Brazil Influenza Medication Market Size, 2016-2027
6.7.4 Argentina Influenza Medication Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Influenza Medication Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Influenza Medication Sales, 2016-2027
6.8.3 Turkey Influenza Medication Market Size, 2016-2027
6.8.4 Israel Influenza Medication Market Size, 2016-2027
6.8.5 Saudi Arabia Influenza Medication Market Size, 2016-2027
6.8.6 UAE Influenza Medication Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Daiichi Sankyo Company
7.1.1 Daiichi Sankyo Company Corporate Summary
7.1.2 Daiichi Sankyo Company Business Overview
7.1.3 Daiichi Sankyo Company Influenza Medication Major Product Offerings
7.1.4 Daiichi Sankyo Company Influenza Medication Sales and Revenue in Global (2016-2021)
7.1.5 Daiichi Sankyo Company Key News
7.2 GlaxoSmithKline
7.2.1 GlaxoSmithKline Corporate Summary
7.2.2 GlaxoSmithKline Business Overview
7.2.3 GlaxoSmithKline Influenza Medication Major Product Offerings
7.2.4 GlaxoSmithKline Influenza Medication Sales and Revenue in Global (2016-2021)
7.2.5 GlaxoSmithKline Key News
7.3 Natco Pharma
7.3.1 Natco Pharma Corporate Summary
7.3.2 Natco Pharma Business Overview
7.3.3 Natco Pharma Influenza Medication Major Product Offerings
7.3.4 Natco Pharma Influenza Medication Sales and Revenue in Global (2016-2021)
7.3.5 Natco Pharma Key News
7.4 F. Hoffmann-La Roche
7.4.1 F. Hoffmann-La Roche Corporate Summary
7.4.2 F. Hoffmann-La Roche Business Overview
7.4.3 F. Hoffmann-La Roche Influenza Medication Major Product Offerings
7.4.4 F. Hoffmann-La Roche Influenza Medication Sales and Revenue in Global (2016-2021)
7.4.5 F. Hoffmann-La Roche Key News
7.5 Teva Pharmaceutical
7.5.1 Teva Pharmaceutical Corporate Summary
7.5.2 Teva Pharmaceutical Business Overview
7.5.3 Teva Pharmaceutical Influenza Medication Major Product Offerings
7.5.4 Teva Pharmaceutical Influenza Medication Sales and Revenue in Global (2016-2021)
7.5.5 Teva Pharmaceutical Key News
7.6 Sandoz International
7.6.1 Sandoz International Corporate Summary
7.6.2 Sandoz International Business Overview
7.6.3 Sandoz International Influenza Medication Major Product Offerings
7.6.4 Sandoz International Influenza Medication Sales and Revenue in Global (2016-2021)
7.6.5 Sandoz International Key News
7.7 Sun Pharmaceutical Industries
7.7.1 Sun Pharmaceutical Industries Corporate Summary
7.7.2 Sun Pharmaceutical Industries Business Overview
7.7.3 Sun Pharmaceutical Industries Influenza Medication Major Product Offerings
7.4.4 Sun Pharmaceutical Industries Influenza Medication Sales and Revenue in Global (2016-2021)
7.7.5 Sun Pharmaceutical Industries Key News
7.8 Mylan
7.8.1 Mylan Corporate Summary
7.8.2 Mylan Business Overview
7.8.3 Mylan Influenza Medication Major Product Offerings
7.8.4 Mylan Influenza Medication Sales and Revenue in Global (2016-2021)
7.8.5 Mylan Key News
8 Global Influenza Medication Production Capacity, Analysis
8.1 Global Influenza Medication Production Capacity, 2016-2027
8.2 Influenza Medication Production Capacity of Key Manufacturers in Global Market
8.3 Global Influenza Medication Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Influenza Medication Supply Chain Analysis
10.1 Influenza Medication Industry Value Chain
10.2 Influenza Medication Upstream Market
10.3 Influenza Medication Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Influenza Medication Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer


List of Tables
Table 1. Key Players of Influenza Medication in Global Market
Table 2. Top Influenza Medication Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Influenza Medication Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Influenza Medication Revenue Share by Companies, 2016-2021
Table 5. Global Influenza Medication Sales by Companies, (K Units), 2016-2021
Table 6. Global Influenza Medication Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Influenza Medication Price (2016-2021) & (USD/Unit)
Table 8. Global Manufacturers Influenza Medication Product Type
Table 9. List of Global Tier 1 Influenza Medication Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Influenza Medication Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type